Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing



Status:Completed
Conditions:Allergy, Asthma, Hospital
Therapuetic Areas:Otolaryngology, Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:March 2009
End Date:January 2014

Use our guide to learn which trials are right for you!

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair(R) Dosing

This study will establish a clinical data and serum repository of anaphylaxis cases
associated with Xolair administration and control patients who have received Xolair without
associated anaphylaxis. This is an observational repository and not an investigational
clinical trial. Associated with the repository is an optional skin testing substudy.


Inclusion Criteria for Cases:

- Confirmed anaphylaxis based on Sampson criteria subsequent to Xolair

Inclusion Criteria for Controls:

- At least 1 patient control among 4 controls who discontinued Xolair for at least 16
weeks but not more than 18 months at enrollment

- At least one dose of Xolair in the 18 months before the date of the case event (index
date)

- No prior anaphylaxis or other hypersensitivity reaction subsequent to Xolair dosing,
including any reactions to its components
We found this trial at
7
sites
?
mi
from
Valrico, FL
Click here to add this to my saved trials
?
mi
from
Blue Bell, PA
Click here to add this to my saved trials
?
mi
from
Hinsdale, IL
Click here to add this to my saved trials
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials